Van de Verg L - Search Results

1

Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects.

Chakraborty S, Harro C, DeNearing B, Bream J, Bauers N, Dally L, Flores J, Van de Verg L, Sack DA, Walker R. Chakraborty S, et al. Among authors: van de verg l. Clin Vaccine Immunol. 2016 Apr 4;23(4):315-25. doi: 10.1128/CVI.00608-15. Print 2016 Apr. Clin Vaccine Immunol. 2016. PMID: 26865592 Free PMC article. Clinical Trial.

2

Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial.

McKenzie R, Walker RI, Nabors GS, Van De Verg LL, Carpenter C, Gomes G, Forbes E, Tian JH, Yang HH, Pace JL, Jackson WJ, Bourgeois AL. McKenzie R, et al. Among authors: van de verg ll. Vaccine. 2006 May 1;24(18):3735-45. doi: 10.1016/j.vaccine.2005.07.014. Epub 2005 Jul 21. Vaccine. 2006. PMID: 16095766 Clinical Trial.

3

Safety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic Escherichia coli.

El-Kamary SS, Cohen MB, Bourgeois AL, Van De Verg L, Bauers N, Reymann M, Pasetti MF, Chen WH. El-Kamary SS, et al. Among authors: van de verg l. Clin Vaccine Immunol. 2013 Nov;20(11):1764-70. doi: 10.1128/CVI.00464-13. Epub 2013 Sep 18. Clin Vaccine Immunol. 2013. PMID: 24049109 Free PMC article. Clinical Trial.

4

Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccine.

Kaminski RW, Wu M, Turbyfill KR, Clarkson K, Tai B, Bourgeois AL, Van De Verg LL, Walker RI, Oaks EV. Kaminski RW, et al. Among authors: van de verg ll. Clin Vaccine Immunol. 2014 Mar;21(3):366-82. doi: 10.1128/CVI.00683-13. Epub 2014 Jan 8. Clin Vaccine Immunol. 2014. PMID: 24403527 Free PMC article.

5

Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes.

Heine SJ, Diaz-McNair J, Andar AU, Drachenberg CB, van de Verg L, Walker R, Picking WL, Pasetti MF. Heine SJ, et al. Among authors: van de verg l. J Immunol. 2014 Feb 15;192(4):1630-40. doi: 10.4049/jimmunol.1302743. Epub 2014 Jan 22. J Immunol. 2014. PMID: 24453241 Free PMC article.

6

Outpatient studies of the safety and immunogenicity of an auxotrophic Escherichia coli K-12-Shigella flexneri 2a hybrid vaccine candidate, EcSf2a-2.

Taylor DN, Phillip DF, Zapor M, Trofa A, Van de Verg L, Hartman A, Bendiuk N, Newland JW, Formal SB, Sadoff JC, et al. Taylor DN, et al. Among authors: van de verg l. Vaccine. 1994 May;12(6):565-8. doi: 10.1016/0264-410x(94)90318-2. Vaccine. 1994. PMID: 8036831 Clinical Trial.

7

Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine.

Martinez-Becerra FJ, Chen X, Dickenson NE, Choudhari SP, Harrison K, Clements JD, Picking WD, Van De Verg LL, Walker RI, Picking WL. Martinez-Becerra FJ, et al. Among authors: van de verg ll. Infect Immun. 2013 Dec;81(12):4470-7. doi: 10.1128/IAI.00859-13. Epub 2013 Sep 23. Infect Immun. 2013. PMID: 24060976 Free PMC article.

8

Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease.

Herrington DA, Van de Verg L, Formal SB, Hale TL, Tall BD, Cryz SJ, Tramont EC, Levine MM. Herrington DA, et al. Among authors: van de verg l. Vaccine. 1990 Aug;8(4):353-7. doi: 10.1016/0264-410x(90)90094-3. Vaccine. 1990. PMID: 2204243 Clinical Trial.

9

Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model.

Mallett CP, VanDeVerg L, Collins HH, Hale TL. Mallett CP, et al. Vaccine. 1993;11(2):190-6. doi: 10.1016/0264-410x(93)90016-q. Vaccine. 1993. PMID: 8438617

10

Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection.

Van De Verg LL, Bendiuk NO, Kotloff K, Marsh MM, Ruckert JL, Puryear JL, Taylor DN, Hartman AB. Van De Verg LL, et al. Vaccine. 1996 Aug;14(11):1062-8. doi: 10.1016/0264-410x(96)00006-0. Vaccine. 1996. PMID: 8879103

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters